CXCR4 blockade by LY2510924 inhibited the phosphorylation of ERK, which partially abrogated the stroma-mediated bypass of the FLT3 receptor, enhanced the apoptosis by quizartinib in co-culture conditions and facilitated anti-leukemia effects in vivo. The gene discussed is CXCR4; the disease is leukemia.